IMPAX to Present at CIBC World Markets Biotechnology & Specialty Pharmaceuticals Conference

April 24, 2003

April 24, 2003--IMPAX Laboratories, Inc. (Nasdaq:IPXL) today announced that management will present at the CIBC World Markets Biotechnology & Specialty Pharmaceuticals Conference on Wednesday, April 30, 2003 at 2:30 p.m. ET. The conference will be held from April 30 to May 1, 2003 at the Millennium Broadway Hotel in New York.

Individuals may listen to both the live and archived webcast until Monday, June 2, 2003 at the following address: In addition, a link to the live and archived presentation will be posted on the investor relations portion of the Company's web site at

IMPAX Laboratories, Inc. is a technology based specialty pharmaceutical company applying its formulation expertise and drug delivery technology to the development of controlled-release and specialty generics in addition to the development of branded products. IMPAX markets its generic products through its Global Pharmaceuticals division and intends to market its branded products through the IMPAX Pharmaceuticals division. Additionally, where strategically appropriate, IMPAX has developed marketing partnerships to fully leverage its technology platform. IMPAX Laboratories is headquartered in Hayward, California, and has a full range of capabilities in its Hayward and Philadelphia